August 2, 2004
Researchers at the Uppsala Branch of the Ludwig Institute for Cancer Research have discovered that the transcription factor Yin Yang 1 (YY1) is a novel regulator of the p53 tumor suppressor p53, making YY1 a new target for future therapies.